The market for advanced cell models is booming and expected to grow from $1.42 billion in 2022 to $5.29 billion by 2032. This surge is driven by the unique properties of advanced cell models: They can offer a more accurate representation of human tissues than traditional 2D cultures. As a result, 3D cell models are increasingly becoming a valuable tool for enhancing our understanding of healthy physiology and disease mechanisms.
3D organoids stand out amongst other advanced cell models for their nuanced simulation of human organs. Our comprehensive report, sponsored by Sartorius, examines the evolution, advantages, current applications and future potential of 3D organoids.
Download the report to discover how 3D organoids are transforming research in oncology, neuroscience, and immunology, and their potential in further advancing drug development.
"*" indicates required fields